Top Markets
#1 Black Phoenix Black Phoenix +366.60%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +55.41%
#4 Gold Park Gold Park +55.06%
#5 Acurast Acurast +36.69%
#6 BasedHype BasedHype +29.98%
#7 Avantis Avantis +25.39%
#8 Cryptopia Cryptopia +22.04%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.42%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.20%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Kedudukan dalam Saham #40877
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Harga Saham
$0.013
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$68.05K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-66.67%
Negara
US
Perdagangan Vincerx Pharma, Inc. (VINC)

Kategori

Healthcare
Sejarah harga saham bagi Vincerx Pharma, Inc. (VINC)
Harga penutupan tertinggi: $0.01 pada 2026-08-01

Harga penutupan terendah: $195.93 pada 2020-05-01
Sejarah harga saham Vincerx Pharma, Inc. dari 2020 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 86.65%
2025 -99.71%
2024 -70.59%
2023 -10.91%
2022 -91.75%
2021 -41.58%
2020 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $524.78 32.55%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $872.51 34.94%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $746.26 9.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $260.72 17.02%
BE